Labcorp Holdings Inc.

As of June 30, 2026, Labcorp Holdings Inc. carries a market capitalization of 19.58B, placing it among publicly traded companies globally. Its enterprise value stands at 25.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Labcorp Holdings Inc.'s next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, Labcorp Holdings Inc. has 80.90M shares outstanding.

As of June 30, 2026, Labcorp Holdings Inc. trades at a trailing price-to-earnings ratio of 22.73. The price-to-sales ratio is 1.59, and the price-to-book ratio stands at 2.60.

As of June 30, 2026, Labcorp Holdings Inc. trades at an EV/EBITDA multiple of 13.23 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 19.38 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Labcorp Holdings Inc. trades at an EV/FCF ratio of 15.91, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 25.39B versus a market cap of 19.58B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Labcorp Holdings Inc. maintains a current ratio of 1.80, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 78.46, indicating elevated leverage, while an interest coverage ratio of 9.65 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Labcorp Holdings Inc. posted a return on equity (ROE) of 11.74, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 8.02 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.48, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.80, useful for judging operating efficiency across full business cycles. The company generates approximately 177,509.60 in revenue per employee across its workforce of 70,750.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.07 indicates how many times Labcorp Holdings Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Labcorp Holdings Inc. recorded 201.49M in income tax expense. That works out to an effective tax rate of 18.66, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.08B, leaving 877.31M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Labcorp Holdings Inc.'s stock has gained approximately 20.83% over the past 52 weeks. The 50-day moving average sits at 277.24, while the 200-day moving average is 242.55.

Over the twelve months ended June 30, 2026, Labcorp Holdings Inc. generated 12.56B in revenue and converted that into 877.31M in net income, yielding earnings per share of 10.59. EBITDA reached 1.92B, while operating income came in at 1.43B.

As of June 30, 2026, Labcorp Holdings Inc. holds 124.12M in cash and equivalents against 5.92B in total debt, resulting in a net debt position of 5.00B. Total book value stands at 7.53B, with working capital of 1.48B providing operational flexibility.

Labcorp Holdings Inc. produced 1.43B in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Labcorp Holdings Inc. posted a gross margin of 28.88, reflecting its pricing power and cost economics. The operating margin of 11.35 and net profit margin of 6.99 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Labcorp Holdings Inc. paid dividends of 2.54 per share. The dividend payout ratio of 23.80 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 7.14, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.08, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Labcorp Holdings Inc. shareholders.

Labcorp Holdings Inc.'s most recent stock split took place on May 13, 2002 with a 1:2 split ratio.

As of June 30, 2026, Labcorp Holdings Inc. has an Altman Z-Score of 5.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.